Shining Light on Hidradenitis Suppurativa (HS):
Research Results and Moving Forward

Summary of Program Goals:

Engage a broad group of stakeholders, particularly patients affected by Hidradenitis Suppurativa (HS) and the clinicians interested in their care, to share recent advances in research and a brief update of the treatment pipeline.

Program Agenda:

1. What is Hidradenitis Suppurativa (HS)? 
2. The HS Translational Roadmap  
3. Patient Research Participation  
4. Return of Results from studies at Rockefeller University  
5. What’s Coming down the Pipeline for HS

Speakers:

	Michelle A Lowes, MBBS, PhD Visiting Associate Attending Physician The Rockefeller University Director, HS Foundation
	James G Krueger, MD, PhD  D. Martin Carter Professor in Clinical Investigation Senior Attending Physician Laboratory Head, Investigative Dermatology Principal Investigator, Center for Clinical and Translational Science The Rockefeller University
	John W Frew, MBBS, MMed, MS, FACD Lecturer, University of New South Wales Department of Dermatology Liverpool Hospital, Australia
	Yael Renert-Yuval, MD, MS Instructor in Clinical Investigation Laboratory for Investigative Dermatology The Rockefeller University
	Athena M Gierbolini Patient Advocate Community Lead and Director, Hope for HS Director, HS Foundation

A live webinar brought to you by:

The Rockefeller University Center for Clinical and Translational Science 
Clinical Directors Network, Inc. (CDN) 

This webinar is approved for up to 1.0 prescribed Continuing Medical Education (CME) Credits and Continuing Nursing Education (CNE) credits by
The American Academy of Family Physicians (AAFP)

www.CDNetwork.org